The latest announcement is out from Portage Biotech Inc ( (PRTG) ).
Portage Biotech Inc., a company engaged in the development and commercialization of immuno-oncology therapies, has announced a significant leadership change. Alexander Pickett has been appointed as the new Chief Executive Officer and a member of the Board of Directors, effective December 15, 2024. This leadership transition may impact the company’s strategic direction and operations, potentially influencing its position within the biotechnology sector.
More about Portage Biotech Inc
YTD Price Performance: -89.51%
Average Trading Volume: 927,097
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $4.28M
For an in-depth examination of PRTG stock, go to TipRanks’ Stock Analysis page.